Yumiko Komatsu
Affiliations: | Biomedical Sciences | Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada |
Google:
"Yumiko Komatsu"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Takumi S, Tomioka M, Yunoki Y, et al. (2023) Microcystin-LR-induced epithelial-mesenchymal transition-like cells acquire resistance to multi-toxins. Toxicon : Official Journal of the International Society On Toxinology. 238: 107592 |
Takumi S, Hashimoto K, Tomioka M, et al. (2023) Acteoside from Conandron ramondioides Reduces Microcystin-LR Cytotoxicity by Inhibiting Intracellular Uptake Mediated by OATP1B3. Planta Medica |
Komatsu Y, Derwish L, Hirasawa K. (2016) IRF1 Downregulation by Ras/MEK Is Independent of Translational Control of IRF1 mRNA. Plos One. 11: e0160529 |
Fairbridge NA, Southall TM, Ayre DC, et al. (2015) Loss of CD24 in Mice Leads to Metabolic Dysfunctions and a Reduction in White Adipocyte Tissue. Plos One. 10: e0141966 |
Komatsu Y, Hirasawa K, Christian SL. (2015) Global gene analysis identifying genes commonly regulated by the Ras/Raf/MEK and type I IFN pathways. Genomics Data. 4: 84-7 |
AbuSara N, Razavi S, Derwish L, et al. (2015) Restoration of IRF1-dependent anticancer effects by MEK inhibition in human cancer cells. Cancer Letters. 357: 575-81 |
Komatsu Y, Christian SL, Ho N, et al. (2015) Oncogenic Ras inhibits IRF1 to promote viral oncolysis. Oncogene. 34: 3985-93 |
Komatsu Y, Christian SL, Ho N, et al. (2015) 628. Oncogenic Ras Inhibits IRF1 To Promote Viral Oncolysis Molecular Therapy. 23: S249 |
Mostafa AA, Codner D, Hirasawa K, et al. (2014) Activation of ERα signaling differentially modulates IFN-γ induced HLA-class II expression in breast cancer cells. Plos One. 9: e87377 |
Christian SL, Zu D, Licursi M, et al. (2012) Suppression of IFN-induced transcription underlies IFN defects generated by activated Ras/MEK in human cancer cells. Plos One. 7: e44267 |